28
ANZUP ANNUAL REPORT 2021
AT A GLANCE
Fundraising, Partnerships and Engagement Thanks to the support from our committed and passionate supporters and donors, we continue to help improve the lives of people affected by below the belt cancers through clinical trials research. Although the last 12 months have been difficult for many people, we are very grateful to all the individuals, families, volunteers, corporations, workplaces and other organisations that supported us and continued to remain committed to help ANZUP reach our goals.
In January 2021 ANZUP launched a penile cancer research appeal to raise not only funds, but also awareness. The appeal aims to fund research to gain further understanding of the interaction needed between the various services, the patients and their partners and families to ensure the best possible physical and mental outcomes. ANZUP is also working on ongoing communications and case studies to go to selected media outlets to educate and raise awareness about this cancer.
The generous and ongoing support from the community not only raises awareness for ANZUP but invests in worthwhile projects, novel trials all the way to full scale clinical trials, to make a difference to the lives to people diagnosed with below the belt cancers, their families and future generations.
Penile Cancer Appeal 2021
ACCEPT STUDY PI PROF DICKON HAYNE
Special donations In July 2020 ANZUP was delighted to receive funding from the McCusker Foundation for the ACCEPT study. The support will assist with the development of the first national secure online database for radical cystectomy patients. The study will help analyse outcomes, provide further information, improve best practice and standards in bladder cancer treatment. ANZUP is extremely grateful to the McCusker Foundation for their support. Penile cancer is a rare but significant male cancer with a complete lack of any research in Australia. As part of ANZUP’s Bladder, Urothelial and Penile (BUP) subcommittee and disease portfolio, ANZUP is dedicated to finding more answers and to gain a comprehensive picture of how this disease can best be treated now and into the future.